Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions

Journal of Oral Pathology and Medicine

Volumn 33, Issue 2, 2004, Pages 65-70

  Fischer, Dena J ^a,b   Epstein, Joel B ^a,c   Morton Jr , Thomas H ^a   Schwartz, Stephen M ^b,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Mouth diseases diagnosis; Mouth mucosa pathology; Mouth neoplasms diagnosis; Observer variation; Oral leukoplakia diagnosis; Oral pathology

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CARCINOMA IN SITU; CHEEK MUCOSA; CLINICAL PROTOCOL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LEUKOPLAKIA; LIP; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OBSERVER VARIATION; ORAL BIOPSY; PATHOLOGIST; PRIORITY JOURNAL; RELIABILITY; TONGUE; VESTIBULE;

ALCOHOL DRINKING; BIOPSY; CARCINOMA; CARCINOMA IN SITU; FEMALE; HUMANS; HYPERPLASIA; INFLAMMATION; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; OBSERVER VARIATION; PATHOLOGY, ORAL; PRECANCEROUS CONDITIONS; RISK FACTORS; SMOKING;

EID: 0842305821     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.0037n.x     Document Type: Article

References (25)

1. American Cancer Society. Cancer Facts & Figures 2003. Atlanta: American Cancer Society Inc., 2003.
2. Mashburg A. Diagnosis of early oral and oropharyngeal squamous carcinoma: obstacles and their amelioration. Oral Oncol 2000; 26: 253-5.
3. Silverman S, Gorsky M, Kaugars GE. Leukoplakia, dysplasia, and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 117.
4. WHO Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. J Oral Surg 1978; 46 (4): 518-39.
5. Pindborg JJ, Reichart PA, Smith CJ, van der Waal J. Histological Typing of Cancer and Precancer of the Oral Mucosa, 2nd edn. Springer, New York: World Health Organization, 1997.
6. Warnakulasuriya S. Histological grading of oral epithelial dysplasia: revisited. J Pathol 2001; 194: 294-7.
7. Pindborg JJ, Reibel J, Holmstrup P. Subjectivity in evaluating oral epithelial dysplasia, carcinoma in situ, and initial carcinoma. J Oral Pathol 1985; 14: 698-708.
8. Karabulut A, Reibel J, Therkildesn MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995; 24: 198-200.
9. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 80: 188-91.
10. Sudbo J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. J Pathol 2001; 194: 303-10.
11. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. Oxford: Oxford University Press, 1992, pp. 78-114.
12. Ringsted J, Amtrup F, Asklund C, et al. Reliability of histopathological diagnosis of squamous epithelial changes of the uterine cervix. Acta Pathol Microbiol Scand Sect A 1978; 86: 273-8.
13. De vet HC, Knipschild PG, Schouten HJ, et al. Interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol 1990; 43: 1395-8.
14. De vet HC, Knipschild PG, Schouten HJ, et al. Sources of interobserver variation in histopathological grading of cervical dysplasia. J Clin Epidemiol 1992; 45 (7): 785-90.
15. Bosman FT. Dysplasia classification: pathology in disgrace? J Pathol 2001; 194: 143-4.
16. Henson DE. Studies on observer variation should the rules be changed? Arch Pathol Laboratory Med 1991; 115 (10): 991-2.
17. Sudbo J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. New Engl J Med 2001; 344 (17): 1270-8.
18. Rosin MP, Cheng X, Poh CF, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res 2000; 6 (2): 357-62.
19. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosome 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996; 2 (6): 682-5.
20. Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A'Hern RP, Langdon JD. A case control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. Cancer Res 2000; 60 (14): 3893-8.
21. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000; 6 (5): 1702-10.
22. Mao L. Can molecular assessment improve classification of head and neck premalignancy? Clin Cancer Res 2000; 6: 321-2.
23. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000; 6 (2): 347-52.
24. Cairns P, Sidransky D. Molecular methods for the diagnosis of cancer. Biochim Biophys Acta 1999; 1423 (2): C11-8.
25. Ahrendt SA, Sidransky D. The potential of molecular screening. Surg Oncol Clinics N Am 1999; 8 (4): 641-56.